PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32386261-4	2020	An aqueous dispersion of beta-TCP fine particles was added to RCP to obtain RCP/beta-TCP.	beta-tricalcium phosphate	25-33	CGRP receptor component	Homo sapiens	62-65	
32386261-4	2020	An aqueous dispersion of beta-TCP fine particles was added to RCP to obtain RCP/beta-TCP.	beta-tricalcium phosphate	25-33	CGRP receptor component	Homo sapiens	76-79	
32386261-7	2020	In SEM and EDX analyses of RCP/beta-TCP, beta-TCP particles dose-dependently covered the surface of RCP.	beta-tricalcium phosphate	41-49	CGRP receptor component	Homo sapiens	27-30	
32386261-7	2020	In SEM and EDX analyses of RCP/beta-TCP, beta-TCP particles dose-dependently covered the surface of RCP.	beta-tricalcium phosphate	41-49	CGRP receptor component	Homo sapiens	100-103	
32386261-9	2020	Histomorphometric assessment at 4 weeks showed that RCP/beta-TCP significantly promoted new skull bone formation compared to RCP (p < 0.05) and control (no application) (p < 0.01).	beta-tricalcium phosphate	56-64	CGRP receptor component	Homo sapiens	52-55	
32386261-10	2020	Accordingly, these findings suggest RCP/beta-TCP possess bone forming capability and would be beneficial for bone tissue engineering therapy.	beta-tricalcium phosphate	40-48	CGRP receptor component	Homo sapiens	36-39